The scared and lofty corporate ideal is a banner that we sincerely look up to in the climbling and tha continuous improvement of corporate culture always shines on the course of corporate development.
The national key high-tech enterprise-Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded by Academician Wu Yiling of the Chinese Academy of Engineering. Under his leadership, Yiling Pharmaceutical has always adhered to the technological innovation and development strategy of taking science and technology as the leader and market as the leader. The unique five-in-one operation model of "theory-clinical-research-industry-teaching" establishes a new drug R&D and innovation technology system guided by the theoretical innovation of TCM collateral disease.
2020 China's 500 Most Valuable Brands
Top 500 listed companies in China by market value
Demonstration base for the industrialization of national high-tech research and development plans
International Science and Technology Cooperation Center of the Ministry of Science and Technology
Top Ten Brand Enterprises of Chinese National Medicine
Top 50 Small and Medium-sized Boards of China's Listed Companies
Top Ten Chinese Traditional Medicine Product Brands
Top 20 listed pharmaceutical companies in China
member of China Engineering Academy
Director of the State Key Laboratory of Collateral Disease Research and Innovative Chinese Medicine
Deputy Chairman of the Expert Committee of the National Center for Cardiovascular Diseases
Member of the Chinese Academy of Medical Sciences
Director of the Key Laboratory of Collateral Diseases, State Administration of Traditional Chinese Medicine
Honorary Vice President of Chinese Society of Chinese Medicine
Honorary President of China Association of Integrative Medicine
Vice President of Chinese Medical Doctor Association
Vice Chairman of World Federation of Chinese Medicine Societies
Honorary Chairman of the Chinese Society of Chinese Medicine Luo Disease Branch
The national key high-tech enterprise-Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded by Academician Wu Yiling of the Chinese Academy of Engineering. Under his leadership, Yiling Pharmaceutical has always adhered to the technological innovation and development strategy of taking science and technology as the leader and market as the leader. The unique five-in-one operation model of "theory-clinical-research-industry-teaching" establishes a new drug R&D and innovation technology system guided by the theoretical innovation of TCM collateral disease.
